{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:59:35Z","timestamp":1792094375560,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012542","name":"Science and Technology Support Program of Sichuan Province","doi-asserted-by":"crossref","award":["2022NSFSC0828"],"award-info":[{"award-number":["2022NSFSC0828"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82120108015"],"award-info":[{"award-number":["82120108015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371925"],"award-info":[{"award-number":["82371925"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Province central government guide local science and technology development project","award":["2023ZYD0100"],"award-info":[{"award-number":["2023ZYD0100"]}]},{"name":"1\u20133\u20135 project for disciplines of excellence of West China Hospital, Sichuan University","award":["ZYGD23019"],"award-info":[{"award-number":["ZYGD23019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02594-y","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T22:30:42Z","timestamp":1737239442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The additional impact of metabolic syndrome on left ventricular deformation and myocardial energetic efficiency impairment in ischemia with nonobstructive coronary arteries patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Chen-Yan","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ning","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Kun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"issue":"8","key":"2594_CR1","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","volume":"149","author":"SS Martin","year":"2024","unstructured":"Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Barone Gibbs B, Beaton AZ, Boehme AK, et al. 2024 Heart Disease and Stroke statistics: a report of US and Global Data from the American Heart Association. Circulation. 2024;149(8):e347\u2013913.","journal-title":"Circulation"},{"issue":"1","key":"2594_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jcmg.2022.06.015","volume":"16","author":"HR Reynolds","year":"2023","unstructured":"Reynolds HR, Diaz A, Cyr DD, Shaw LJ, Mancini GBJ, Leipsic J, Budoff MJ, Min JK, Hague CJ, Berman DS, et al. Ischemia with nonobstructive coronary arteries: insights from the ISCHEMIA Trial. JACC Cardiovasc Imaging. 2023;16(1):63\u201374.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2594_CR3","doi-asserted-by":"crossref","unstructured":"Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, Dixon DL, Fearon WF, Hess B, Johnson HM et al. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation 2023, 148(9):e9-e119.","DOI":"10.1161\/CIR.0000000000001183"},{"key":"2594_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijcard.2022.09.047","volume":"371","author":"M Gulati","year":"2023","unstructured":"Gulati M, Khan N, George M, Berry C, Chieffo A, Camici PG, Crea F, Kaski JC, Marzilli M, Merz CNB. Ischemia with no obstructive coronary artery disease (INOCA): a patient self-report quality of life survey from INOCA international. Int J Cardiol. 2023;371:28\u201339.","journal-title":"Int J Cardiol"},{"issue":"1","key":"2594_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12933-024-02230-1","volume":"23","author":"W Zhang","year":"2024","unstructured":"Zhang W, Liu L, Yin G, Mohammed AQ, Xiang L, Lv X, Shi T, Galip J, Wang C, Mohammed AA, et al. Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease. Cardiovasc Diabetol. 2024;23(1):187.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"2594_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","volume":"33","author":"L Jespersen","year":"2012","unstructured":"Jespersen L, Hvelplund A, Abildstr\u00f8m SZ, Pedersen F, Galatius S, Madsen JK, J\u00f8rgensen E, Kelb\u00e6k H, Prescott E. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33(6):734\u201344.","journal-title":"Eur Heart J"},{"key":"2594_CR7","doi-asserted-by":"crossref","unstructured":"Chang A, Kang N, Chung J, Gupta AR, Parwani P. Evaluation of ischemia with no obstructive coronary arteries (INOCA) and contemporary applications of Cardiac magnetic resonance (CMR). Med (Kaunas) 2023, 59(9).","DOI":"10.3390\/medicina59091570"},{"issue":"37","key":"2594_CR8","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","volume":"41","author":"V Kunadian","year":"2020","unstructured":"Kunadian V, Chieffo A, Camici PG, Berry C, Escaned J, Maas A, Prescott E, Karam N, Appelman Y, Fraccaro C, et al. An EAPCI Expert Consensus Document on Ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J. 2020;41(37):3504\u201320.","journal-title":"Eur Heart J"},{"issue":"3","key":"2594_CR9","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.numecd.2022.01.007","volume":"32","author":"FA Abdu","year":"2022","unstructured":"Abdu FA, Mohammed AQ, Liu L, Yin G, Xu S, Mohammed AA, Mareai RM, Xu Y, Che W. Metabolic syndrome and the risk of adverse cardiovascular events in patients with myocardial infarction with non-obstructive coronary arteries. Nutr Metab Cardiovasc Dis. 2022;32(3):666\u201374.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"2594_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12968-023-00944-x","volume":"25","author":"M Guglielmo","year":"2023","unstructured":"Guglielmo M, Arangalage D, Bonino MA, Angelini G, Bonanni M, Pontone G, Pascale P, Leo LA, Faletra F, Schwitter J, et al. Additional value of cardiac magnetic resonance feature tracking parameters for the evaluation of the arrhythmic risk in patients with mitral valve prolapse. J Cardiovasc Magn Reson. 2023;25(1):32.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"7","key":"2594_CR11","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1161\/CIRCULATIONAHA.106.660639","volume":"115","author":"P Knaapen","year":"2007","unstructured":"Knaapen P, Germans T, Knuuti J, Paulus WJ, Dijkmans PA, Allaart CP, Lammertsma AA, Visser FC. Myocardial energetics and efficiency: current status of the noninvasive approach. Circulation. 2007;115(7):918\u201327.","journal-title":"Circulation"},{"key":"2594_CR12","doi-asserted-by":"publisher","first-page":"108883","DOI":"10.1016\/j.diabres.2021.108883","volume":"177","author":"T Vanessa Fiorentino","year":"2021","unstructured":"Vanessa Fiorentino T, Miceli S, Succurro E, Sciacqua A, Andreozzi F, Sesti G. Depressed myocardial mechano-energetic efficiency in subjects with dysglycemia. Diabetes Res Clin Pract. 2021;177:108883.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"2594_CR13","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1002\/jmri.28455","volume":"57","author":"S Huang","year":"2023","unstructured":"Huang S, Li Y, Shi K, Wang J, Jiang L, Gao Y, Yan WF, Yang ZG. Impact of metabolic syndrome on left ventricular deformation and myocardial energetic efficiency compared between women and men: an MRI study. J Magn Reson Imaging. 2023;57(6):1743\u201351.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"2594_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12933-022-01733-z","volume":"22","author":"E Succurro","year":"2023","unstructured":"Succurro E, Cicone F, Papa A, Miceli S, Vizza P, Fiorentino TV, Perticone M, Sciacqua A, Guzzi PH, Veltri P, et al. Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance. Cardiovasc Diabetol. 2023;22(1):4.","journal-title":"Cardiovasc Diabetol"},{"key":"2594_CR15","doi-asserted-by":"crossref","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120(16):1640\u20131645.","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"issue":"1","key":"2594_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12933-024-02225-y","volume":"23","author":"CY Min","year":"2024","unstructured":"Min CY, Gao Y, Jiang YN, Guo YK, Shi K, Yang ZG, Li Y. The additive effect of metabolic syndrome on left ventricular impairment in patients with obstructive coronary artery disease assessed by 3.0 T cardiac magnetic resonance feature tracking. Cardiovasc Diabetol. 2024;23(1):133.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"2594_CR17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.7326\/M15-3016","volume":"164","author":"JJ Chamberlain","year":"2016","unstructured":"Chamberlain JJ, Rhinehart AS, Shaefer CF Jr., Neuman A. Diagnosis and management of diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med. 2016;164(8):542\u201352.","journal-title":"Ann Intern Med"},{"issue":"9403","key":"2594_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"Appropriate body-mass","year":"2004","unstructured":"Appropriate body-mass. Index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157\u201363.","journal-title":"Lancet"},{"issue":"33","key":"2594_CR19","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"12","key":"2594_CR20","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.2337\/dc18-0476","volume":"41","author":"D Pongrac Barlovic","year":"2018","unstructured":"Pongrac Barlovic D, Harjutsalo V, Gordin D, Kallio M, Forsblom C, King G, Groop PH. The Association of Severe Diabetic Retinopathy with Cardiovascular Outcomes in Long-standing type 1 diabetes: a Longitudinal follow-up. Diabetes Care. 2018;41(12):2487\u201394.","journal-title":"Diabetes Care"},{"issue":"1","key":"2594_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12933-022-01467-y","volume":"21","author":"J Wang","year":"2022","unstructured":"Wang J, Li Y, Guo YK, Huang S, Shi R, Yan WF, Qian WL, He GX, Yang ZG. The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study. Cardiovasc Diabetol. 2022;21(1):30.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"2594_CR22","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jcmg.2015.10.027","volume":"9","author":"SJ Boynton","year":"2016","unstructured":"Boynton SJ, Geske JB, Dispenzieri A, Syed IS, Hanson TJ, Grogan M, Araoz PA. LGE provides incremental prognostic information over serum biomarkers in AL Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2016;9(6):680\u20136.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"2594_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/HJH.0b013e328320ab97","volume":"27","author":"G de Simone","year":"2009","unstructured":"de Simone G, Chinali M, Galderisi M, Benincasa M, Girfoglio D, Botta I, D\u2019Addeo G, de Divitiis O. Myocardial mechano-energetic efficiency in hypertensive adults. J Hypertens. 2009;27(3):650\u20135.","journal-title":"J Hypertens"},{"issue":"5","key":"2594_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11883-001-0073-0","volume":"3","author":"JC Plana","year":"2001","unstructured":"Plana JC, Jones PH. The use of statins in acute coronary syndromes: the mechanisms behind the outcomes. Curr Atheroscler Rep. 2001;3(5):355\u201364.","journal-title":"Curr Atheroscler Rep"},{"issue":"1 Pt 1","key":"2594_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jcmg.2018.11.036","volume":"13","author":"TH Schindler","year":"2020","unstructured":"Schindler TH, Dilsizian V. Coronary microvascular dysfunction: clinical considerations and noninvasive diagnosis. JACC Cardiovasc Imaging. 2020;13(1 Pt 1):140\u201355.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2594_CR26","doi-asserted-by":"crossref","unstructured":"Rodriguez-Zanella H, Arbucci R, Fritche-Salazar JF, Ortiz-Leon XA, Tuttolomondo D, Lowenstein DH, Wierzbowska-Drabik K, Ciampi Q, Kasprzak JD, Gaibazzi N et al. Vasodilator strain stress Echocardiography in suspected coronary microvascular angina. J Clin Med 2022, 11(3).","DOI":"10.3390\/jcm11030711"},{"issue":"1","key":"2594_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12933-024-02331-x","volume":"23","author":"M Ferrone","year":"2024","unstructured":"Ferrone M, Ciccarelli M, Varzideh F, Kansakar U, Guerra G, Cerasuolo FA, Buonaiuto A, Fiordelisi A, Venga E, Esposito M, et al. Endothelial microRNAs in INOCA patients with diabetes mellitus. Cardiovasc Diabetol. 2024;23(1):268.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2594_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12872-024-03769-3","volume":"24","author":"M Sarebanhassanabadi","year":"2024","unstructured":"Sarebanhassanabadi M, Mirjalili SR, Marques-Vidal P, Kraemer A, Namayandeh SM. Coronary artery disease incidence, risk factors, awareness, and medication utilization in a 10-year cohort study. BMC Cardiovasc Disord. 2024;24(1):101.","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"2594_CR29","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/cvr\/cvaa023","volume":"116","author":"PG Camici","year":"2020","unstructured":"Camici PG, Tsch\u00f6pe C, Di Carli MF, Rimoldi O, Van Linthout S. Coronary microvascular dysfunction in hypertrophy and heart failure. Cardiovasc Res. 2020;116(4):806\u201316.","journal-title":"Cardiovasc Res"},{"key":"2594_CR30","doi-asserted-by":"crossref","unstructured":"Juszczyk A, Jankowska K, Zawi\u015blak B, Surdacki A, Chyrchel B. Depressed Cardiac Mechanical energetic efficiency: a contributor to Cardiovascular Risk in Common Metabolic diseases-from mechanisms to clinical applications. J Clin Med 2020, 9(9).","DOI":"10.3390\/jcm9092681"},{"issue":"6","key":"2594_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/jhh.2016.88","volume":"31","author":"C Mancusi","year":"2017","unstructured":"Mancusi C, Losi MA, Izzo R, Canciello G, Manzi MV, Sforza A, De Luca N, Trimarco B, de Simone G. Effect of diabetes and metabolic syndrome on myocardial mechano-energetic efficiency in hypertensive patients. The Campania Salute Network. J Hum Hypertens. 2017;31(6):395\u20139.","journal-title":"J Hum Hypertens"},{"issue":"9","key":"2594_CR32","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1097\/HJH.0000000000001007","volume":"34","author":"G de Simone","year":"2016","unstructured":"de Simone G, Izzo R, Losi MA, Stabile E, Rozza F, Canciello G, Mancusi C, Trimarco V, De Luca N, Trimarco B. Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy. J Hypertens. 2016;34(9):1846\u201353.","journal-title":"J Hypertens"},{"issue":"11","key":"2594_CR33","doi-asserted-by":"publisher","first-page":"e1264","DOI":"10.1210\/clinem\/dgad300","volume":"108","author":"CMA Cefalo","year":"2023","unstructured":"Cefalo CMA, Riccio A, Fiorentino TV, Succurro E, Miceli S, Mannino GC, Perticone M, Sciacqua A, Andreozzi F, Sesti G. Metabolic syndrome and C-reactive protein are Associated with a reduced myocardial mechano-energetic Efficiency. J Clin Endocrinol Metab. 2023;108(11):e1264\u201371.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2594_CR34","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/echo.15424","volume":"39","author":"\u0130E Dural","year":"2022","unstructured":"Dural \u0130E, Sar\u0131 A, Ersoy \u0130. Effects of 3 months of treatment with empagliflozin on left ventricle global longitudinal strain and myocardial mechano-energetic effiency. Echocardiography. 2022;39(8):1095\u2013100.","journal-title":"Echocardiography"},{"issue":"1","key":"2594_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2337\/diabetes.50.1.159","volume":"50","author":"F Perticone","year":"2001","unstructured":"Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F, Mattioli PL. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes. 2001;50(1):159\u201365.","journal-title":"Diabetes"},{"issue":"8","key":"2594_CR36","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s11739-023-03402-9","volume":"18","author":"CMA Cefalo","year":"2023","unstructured":"Cefalo CMA, Riccio A, Fiorentino TV, Rubino M, Mannino GC, Succurro E, Perticone M, Sciacqua A, Andreozzi F, Sesti G. Endothelial dysfunction is associated with reduced myocardial mechano-energetic efficiency in drug-na\u00efve hypertensive individuals. Intern Emerg Med. 2023;18(8):2223\u201330.","journal-title":"Intern Emerg Med"},{"issue":"11","key":"2594_CR37","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","volume":"8","author":"JD Sara","year":"2015","unstructured":"Sara JD, Widmer RJ, Matsuzawa Y, Lennon RJ, Lerman LO, Lerman A. Prevalence of coronary microvascular dysfunction among patients with chest Pain and Nonobstructive Coronary Artery Disease. JACC Cardiovasc Interv. 2015;8(11):1445\u201353.","journal-title":"JACC Cardiovasc Interv"},{"key":"2594_CR38","doi-asserted-by":"crossref","unstructured":"Abuhasira R, Burrack N, Turjeman A, Patt YS, Leibovici L, Grossman A. Comparative analysis of first-line antihypertensive treatment classes. Am J Med 2024.","DOI":"10.1016\/j.amjmed.2024.10.016"},{"issue":"1","key":"2594_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/ehjcvp\/pvu020","volume":"1","author":"P Ong","year":"2015","unstructured":"Ong P, Athanasiadis A, Sechtem U. Pharmacotherapy for coronary microvascular dysfunction. Eur Heart J Cardiovasc Pharmacother. 2015;1(1):65\u201371.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"6","key":"2594_CR40","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.ahj.2014.01.017","volume":"167","author":"AA Bavry","year":"2014","unstructured":"Bavry AA, Handberg EM, Huo T, Lerman A, Quyyumi AA, Shufelt C, Sharaf B, Merz CN, Cooper-DeHoff RM, Sopko G, et al. Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the national heart, lung, and blood institute-sponsored women\u2019s ischemia syndrome evaluation. Am Heart J. 2014;167(6):826\u201332.","journal-title":"Am Heart J"},{"key":"2594_CR41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1475-2840-10-80","volume":"10","author":"DJ Campbell","year":"2011","unstructured":"Campbell DJ, Somaratne JB, Jenkins AJ, Prior DL, Yii M, Kenny JF, Newcomb AE, Schalkwijk CG, Black MJ, Kelly DJ. Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease. Cardiovasc Diabetol. 2011;10:80.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02594-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02594-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02594-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T10:22:55Z","timestamp":1737282175000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02594-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2594"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02594-y","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Biomedical Research Ethics Committee of our hospital. Informed consent was waived due to the retrospective nature of the research. The patient\u2011sensitive data were protected with full confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}